In rats, the regulation of CaMKIV activity by genistein displays a beneficial effect in Alzheimer’s disease prevention both on the behavioral (improved spatial learning and memory) and cellular levels (reduced hippocampal neuron damage and level of p-tau) [235]. Here, CAMK4 is linked to early-onset autosomal dominant Alzheimer disease.